Evaluation of the Diagnostic Performance of Fibrin Monomer in Disseminated Intravascular Coagulation
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Fibrin-related markers (FRM) such as fibrin monomer (FM) and D-dimer (DD) are considered useful biological markers for the diagnosis of disseminated intravascular coagulation (DIC). However, no studies on the diagnostic performance of different FRMs have been published in Korea. The aim of this study was to evaluate the diagnostic performance of FM for DIC in comparison with DD. Methods: The reference limit of FM was determined based on plasma sample data obtained from 210 control individuals. To evaluate diagnostic performance, FM data from the plasma samples of 139 patients with DIC-associated diseases were obtained for DIC scoring. FM was measured by immunoturbidimetry using STA-LIATEST FM (Diagnostica Stago, France). Patients were classified according to the DIC score as non-DIC, non-overt DIC, or overt DIC. ROC curve analyses were performed. Results: The reference limit in the control individuals was determined to be 7.80 μg/mL. Patients with DIC-associated diseases were categorized as non-DIC (N=43), non-overt DIC (N=80), and overt DIC (N=16). ROC curve analyses showed that the diagnostic performance of FM was comparable to DD in both non-overt DIC and overt DIC (P=0.596 and 0.553, respectively). In addition, FM had higher sensitivity, specificity, positive predictive value, and negative predictive value than DD for differentiating overt DIC from non-DIC. Conclusions: This study demonstrated that the diagnostic performance of FM for DIC was comparable to DD. FM might be more sensitive and more specific than DD in the diagnosis of overt DIC, but not non-overt DIC.
Abstract
Background: Fibrin-related markers (FRM) such as fibrin monomer (FM) and D-dimer (DD) are considered useful biological markers for the diagnosis of disseminated intravascular coagulation (DIC). However, no studies on the diagnostic performance of different FRMs have been published in Korea. The aim of this study was to evaluate the diagnostic performance of FM for DIC in comparison with DD. Methods: The reference limit of FM was determined based on plasma sample data obtained from 210 control individuals. To evaluate diagnostic performance, FM data from the plasma samples of 139 patients with DIC-associated diseases were obtained for DIC scoring. FM was measured by immunoturbidimetry using STA-LIATEST FM (Diagnostica Stago, France). Patients were classified according to the DIC score as non-DIC, non-overt DIC, or overt DIC. ROC curve analyses were performed. Results: The reference limit in the control individuals was determined to be 7.80 μg/mL. Patients with DIC-associated diseases were categorized as non-DIC (N=43), non-overt DIC (N=80), and overt DIC (N=16). ROC curve analyses showed that the diagnostic performance of FM was comparable to DD in both non-overt DIC and overt DIC (P=0.596 and 0.553, respectively). In addition, FM had higher sensitivity, specificity, positive predictive value, and negative predictive value than DD for differentiating overt DIC from non-DIC. Conclusions: This study demonstrated that the diagnostic performance of FM for DIC was comparable to DD. FM might be more sensitive and more specific than DD in the diagnosis of overt DIC, but not non-overt DIC.
참고문헌 (14)
- Levi M, "Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology", Br J Haematol, 145, pp.24~33 (2009)
- Toh CH, "The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview", J Thromb Haemost, 5, pp.604~606 (2007)
- Taylor FB Jr, "Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation", Thromb Haemost, 86, pp.1327~1330 (2001)
- Wada H, "Are fibrin-related markers useful for the diagnosis of thrombosis", Semin Thromb Hemost, 34, pp.33~38 (2008)
- Wada H, "Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation", Clin Appl Thromb Hemost, 9, pp.233~240 (2003)
- Dempfle CE, "Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score", Thromb Haemost, 91, pp.812~818 (2004)
- Ieko M, "Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis", Clin Chim Acta, 386, pp.38~45 (2007)
- Wada H, "Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation", Am J Hematol, 51, pp.255~260 (1996)
- Toh CH, "Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation", Blood Coagul Fibrinolysis, 16, pp.69~74 (2005)
- Okajima K, "Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation", Am J Hematol, 51, pp.186~191 (1996)
- Hamano A, "Latex immunoturbidimetric assay for soluble fibrin complex", Clin Chem, 51, pp.183~188 (2005)
- Okamoto K, "Frequency and hemostatic abnormalities in pre-DIC patients", Thromb Res, 126, pp.74~78 (2010)
- Egi M, "Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels", Thromb Haemost, 101, pp.696~705 (2009)
- Oh D, "Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis", THROMBOSIS RESEARCH, 126, pp.18~23 (2010), PERGAMON-ELSEVIER SCIENCE LTD